ABSTRACT
Radiomics, the objective study of non-visual features in clinical imaging, has been useful in informing decisions in clinical oncology. However, radiomics currently lacks the ability to characterize the overall structure of the data. This field may benefit by incorporating persistent homology, a popular new algorithm that analyzes whole data structure. We hypothesized that persistent homology could be applied to lung tumor scans and predict clinical variables. We obtained computed tomography lung scans (n = 565) from the NSCLC-Radiomics and NSCLC-Radiogenomics datasets in The Cancer Imaging Archive. Segmentation data was used to create a cubical region centered on the primary tumor in each scan. For each scan, a cubical complex filtration based on Hounsfield units was generated. We created a feature curve that plotted the number of 0 dimensional topological features against each Hounsfield unit. The curve’s first moment of the distribution was utilized as a summary statistic to predict survival in a Cox proportional hazards model. The first moment of the distribution is equivalent to the area under the curve of our topological feature curves (AUC). The Kruskal-Wallis H Test and a post-hoc Dunn’s test with Bonferroni correction were used to test AUC differences among survival quartiles. After controlling for tumor image size, age, and stage, AUC, was associated with poorer survival (HR = 1.118; 95% CI = 1.026-1.218; p = 0.01). AUC was significantly higher for patients in the lowest survival quartile compared to the highest survival quartile (p < 0.001). We have shown that persistent homology can generate useful clinical correlates from tumor CT scans. Our 0-dimensional topological feature curve statistic predicts survival in lung cancer patients. This novel statistic may be used in tandem with standard radiomics variables to better inform clinical oncology decisions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this project was provided by the Case Comprehensive Cancer Center medical student summer research training grant.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A Public Database from The Cancer Imaging Archive was used
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos